Journal articleAnnals of the American Thoracic Society · July 20, 2026
AbstractPulmonary rehabilitation (PR) is a multidisciplinary intervention whose cornerstone is aerobic and resistive exercise training coupled with disease education. Advances in the field of PR have focu ...
Full textCite
Journal articleJ Am Heart Assoc · December 2, 2025
BACKGROUND: Guidelines recommend aspirin (75-100 mg daily) for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). However, it is unknown if people with a history of ASCVD and chronic obstructive pulmonary disease (COPD) or asthma, ...
Full textLink to itemCite
Journal articleAge Ageing · May 31, 2025
Nearly half of premature deaths can be prevented with healthy lifestyle behaviours. However, most older adults do not adhere to established guidelines to promote a healthy lifestyle. We propose a tailored framework of lifestyle medicine that acknowledges t ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · January 21, 2025
BACKGROUND: Meta-analyses have suggested that the risk of cardiovascular disease events is significantly higher after a chronic obstructive pulmonary disease (COPD) exacerbation, but the populations at highest risk have not been well characterized to date. ...
Full textLink to itemCite
Journal articleInt J Chron Obstruct Pulmon Dis · 2025
OBJECTIVE: Fewer than 3% of adults with Chronic Obstructive Pulmonary Disease (COPD) attend in-person, center-based pulmonary rehabilitation (PR) despite demonstrated health benefits and reduction in mortality. This study evaluated the feasibility and usab ...
Full textLink to itemCite
Journal articlePLoS One · 2025
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common and impactful disease that is the target of a large portfolio of clinical research. However, there is limited understanding of how individuals with COPD perceive trial designs, outcomes, ...
Full textLink to itemCite
Journal articleAnn Am Thorac Soc · November 2024
Rationale: Meta-analyses have suggested the risk of cardiovascular disease (CVD) events is significantly higher after a chronic obstructive pulmonary disease (COPD) exacerbation. However, many of these studies have included a broad array of CVD events or h ...
Full textLink to itemCite
Journal articleRespir Care · May 28, 2024
COPD is a common and lethal chronic condition, recognized as a leading cause of death worldwide. COPD is associated with significant morbidity and disability, particularly among older adults. The disease course is marked by periods of stability and disease ...
Full textLink to itemCite
Journal articleRespir Care · December 2022
BACKGROUND: Patients hospitalized for COPD exacerbation have an increased risk of mortality, particularly among those who fail bi-level positive airway pressure (BPAP) for hypercapnic respiratory failure subsequently requiring invasive mechanical ventilati ...
Full textLink to itemCite
Journal articleJAMA Netw Open · June 1, 2022
IMPORTANCE: Pulmonary rehabilitation (PR) after exacerbation of chronic obstructive pulmonary disease (COPD) is effective in reducing COPD hospitalizations and mortality while improving health-related quality of life, yet use of PR remains low. Estimates o ...
Full textLink to itemCite
Journal articleJ Heart Lung Transplant · January 2021
BACKGROUND: Lung transplantation is increasingly performed in recipients aged ≥65 years. However, the risk factors for mortality specific to this population have not been well studied. In lung transplant recipients aged ≥65 years, we sought to determine po ...
Full textLink to itemCite
Journal articleAm Heart J · August 2020
Cardiovascular disease has an increased prevalence among patients with idiopathic pulmonary fibrosis (IPF). Cardiovascular disease and IPF share similar symptoms with overlapping demographics and risk factors for disease development. Common cellular mediat ...
Full textLink to itemCite
Journal articleBMJ Open Respir Res · July 2020
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality. Patient characteristics associated with diagnostic delays are not well described. METHODS: Subjects who had not been diagnosed with IPF prior to referral and rece ...
Full textLink to itemCite
Journal articleJ Hosp Med · October 2017
The prevalence of psychiatric symptoms ranges from 17% to 44% in intensive care unit (ICU) survivors. The relationship between the comorbidity of psychiatric symptoms and quality of life (QoL) in ICU survivors has not been carefully examined. This study ex ...
Full textLink to itemCite
Journal articleJ Hosp Med · September 2017
Nearly 30% of intensive care unit (ICU) survivors have depressive symptoms 2-12 months after hospital discharge. We examined the prevalence of depressive symptoms and risk factors for depressive symptoms in 204 patients at their initial evaluation in the C ...
Full textLink to itemCite